nference Establishes AI Initiative with Takeda to Advance Precision Medicine in Inflammatory Bowel Disease

nference | Moderna Announces New Study Showing Its COVID-19 Vaccine Maintains Antibodies Against Variants of Concern and Interest to 6 Months

Moderna announces new study showing its COVID-19 vaccine maintains antibodies against variants of concern and interest to 6 months.

Moderna Announces New Study Showing Its COVID-19 Vaccine Maintains Antibodies Against Variants of Concern and Interest to 6 Months